2Jelsma J, Maclean E, Hughes J, et al. An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care, 2005,17(5) :579-585.
4Poppa A, Davidson O, Deutsch J, et al. British HIV Association (BHIVA)/British Association for Sexual Health and HIV (BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003). HIV Med, 2004, 5 Suppl 2:46-60.
5Kyngiis H, Duffy ME, Kroll T. Conceptual analysis of compliance. J Clin Nurs, 2000,9( 1 ) :5-12.
6Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med,2000,133( 1 ) :21-30.
7Wolf MS, Davis TC, Osborn CY, et al. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns, 2007, 65 (2) :253-260.
8Colin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretmviral medication. J Gen Intern Med, 2002,17(10) :756-765.
9Roberts KJ, Mann T. Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care, 2000,12 (4): 377-386.
10Holstad MK, Pace JC, De AK, et al. Factors associated with adherence to antiretroviral therapy. J Assoc Nurses AIDS Care, 2006,17(2) :4-15.
7Mannheimer S,Morse E,Matts J,et al.Sustained Benefit From a Long-Term Antiretroviral Adherence Intervention[J].JAIDS,2006,43(1):S41-S47.
8Antoni M,Carrcio A,Duran R,et al.Randomized Clinical Trial of Cognitive Behavioral Stress Management on Human Immunodeficiency Virus Viral Load in Gay Men Treated With Highly Active Antiretroviral Therapy[J].Psychosomatic Medicine,2006,68(1):143-151.
9Crum N,Riffenburgh R,Wegner S,et al.Comparisons of causes of death and mortality rates among HIV-infected persons:analysis of the pre-,early,and late HAART(highly active antiretroviral therapy)eras[J].JAIDS,2006,41:194-200.
10Paterson D,Swindells S,Mohr J,et al.Adherence to protease inhibitor therapy and outcomes in patients with HIV infection[J].Ann Intern Med,2000,133(1):1-30.
